VIDEO + ARTICLE IVIG is an FDA-Approved medication. It has been prescribed off-label for Alzheimer’s. Despite recent failures in clinical trials, pharmaceutical companies and academic
RADIO & ARTICLE Hear Ronald Peterson, head of the U.S. government’s National Alzheimer’s Project Act, explore the results of 4 new studies on bexarotene (Brand
Targacept is taking a confident approach in its latest clinical trial. Rather than pitting their new Alzheimer’s drug against a placebo, they are putting it
VIDEO & ARTICLE Bexarotene is an FDA-approved anti-cancer drug available under the brand name Targretin®. It clears Alzheimer’s biomarkers in mice like a charm. See
50,000 volunteers (with and without Alzheimer’s) are needed to participate in hundreds of clinical trials. People with Alzheimer’s, their families, and those who serve them
In 2012, Envivo’s experimental Alzheimer’s drugs improved cognitive function as the company won a Fierce BioTech Award. Learn about and participate in their newest Phase-2
Merck announced it is enrolling volunteers for the EPOCH clinical trial. Read details on their highly promising MK-8931 treatment for mild-to-moderate Alzheimer’s disease. Find out
VIDEO & ARTICLE Solanezumab slowed Alzheimer’s by 30% in a trial earlier this year. Find out what it’s maker, Ely Lilly, plans for the next step.
VIDEO & ARTICLE In trials, the most effective Alzheimer’s treatment so far is IVIG. At $50,000 per year, learn how scientists hope to bring down
VIDEO Watch this Wall Street Journal interview on why Dr. Wischik sees tau as a more worthwhile anti-Alzheimer’s target than plaque. Learn more about TauRx’
If you couldn’t see your mashed potatoes, you probably wouldn’t eat them. That’s why what “The Red Plate Study” found was astonishing! Alzheimer’s patients eating from red plates consumed 25 percent more food than those eating from white plates. Find out why.
Managing multiple medications can feel overwhelming. The right pill box can turn a daily challenge into a simple routine. We compare Amazon’s best pill organizers for 2025—each designed to meet different needs, from arthritis-friendly lids to monthly systems and automatic dispensers.
New studies highlight smoother tolerability, easier routines, and practical safety updates that make the rivastigmine patch an increasingly caregiver-friendly option.
It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.
What are the early symptoms of Alzheimer’s? When to get a professional evaluation.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.
